Effects of budesonide inhalation on energy expenditure, somatic growth and salivary cortisol levels in preterm infants with chronic lung disease.

@article{Bauer2009EffectsOB,
  title={Effects of budesonide inhalation on energy expenditure, somatic growth and salivary cortisol levels in preterm infants with chronic lung disease.},
  author={Jacqueline Bauer and Ulrike Teufel and Christiane Maser-Gluth and Corinna Doege},
  journal={Hormone research},
  year={2009},
  volume={72 3},
  pages={146-52}
}
BACKGROUND We hypothesized that the use of inhaled budesonide (BUD) would alter somatic growth by increasing energy expenditure (EE) in premature infants with chronic lung disease (CLD). METHODS A prospective study was conducted of the effect of BUD on EE, growth and salivary cortisol excretion in infants with CLD who required supplemental oxygen and were treated with inhaled BUD for 4 weeks according the severity of their CLD, or without BUD treatment. Infants were compared with a healthy… CONTINUE READING